Patent No. US4423724 (titled "Inhalation Device For Powdered Medicaments") was filed by Fisons on Jun 4, 1981. The application was issued on Jan 3, 1984.
'724 is related to the field of inhalation devices, specifically those used to deliver powdered medicaments from capsules. These devices typically involve piercing a capsule containing the powder and then using an airstream to entrain and deliver the medication to the patient. A common problem is that the pierced capsule can remain stuck in the piercing cavity, preventing effective drug delivery.
The underlying idea behind '724 is to ensure that once a capsule is pierced within the device, it is reliably ejected from the piercing cavity into a swirl chamber. This is achieved through a mechanical obstruction that prevents the capsule from re-entering the cavity after being pierced, ensuring it is available for entrainment in the airflow.
The claims of '724 focus on an inhalation device comprising a swirl chamber with air inlets and a mouthpiece, a capsule-receiving cavity in communication with the swirl chamber, and piercing means operable to pierce the capsule and withdraw. Critically, the cavity includes obstructive means to prevent the capsule from re-entering after being pierced.
In practice, the device uses a mechanism, such as a moveable member, to physically block the cavity after piercing. This member can also serve to eject the capsule from the cavity into the swirl chamber. A cam-actuated system can drive both the piercing pins and the ejector mechanism, ensuring a coordinated sequence of piercing, ejection, and obstruction. This ensures the capsule is reliably transferred to the swirl chamber for inhalation.
This design differs from prior approaches that often rely on gravity or airflow alone to dislodge the capsule, which can be unreliable. By introducing a positive mechanical obstruction, the invention ensures that the capsule is actively prevented from returning to the cavity, leading to more consistent and effective drug delivery. The cam-driven ejection provides a reliable method for moving the capsule into the swirl chamber.
In the early 1980s when '724 was filed, inhalation devices for powdered medicaments typically relied on mechanical means to pierce capsules and release medication. At a time when such devices commonly relied on gravity and airflow to dislodge pierced capsules into a swirl chamber, hardware constraints made it non-trivial to ensure consistent capsule ejection and prevent re-entry into the piercing cavity.
The disclosed inhalation device addresses the problem of inconsistent capsule ejection by introducing a mechanism to obstruct the re-entry of the pierced capsule into the piercing cavity. This architectural shift, achieved through a moveable member or constriction, ensures that the capsule is reliably transferred to the swirl chamber, thereby improving the delivery of powdered medicament.
This patent contains zero claims, so there are no independent or dependent claims to analyze.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents